HomeCompareBDVSF vs ABBV

BDVSF vs ABBV: Dividend Comparison 2026

BDVSF yields 3.76% · ABBV yields 3.12%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 ABBV wins by $4.3K in total portfolio value
10 years
BDVSF
BDVSF
● Live price
3.76%
Share price
$13.10
Annual div
$0.49
5Y div CAGR
36.7%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$100.4K
Annual income
$30,477.76
Full BDVSF calculator →
ABBV
AbbVie Inc.
● Live price
3.12%
Share price
$213.22
Annual div
$6.65
5Y div CAGR
40.6%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$104.7K
Annual income
$25,725.73
Full ABBV calculator →

Portfolio growth — BDVSF vs ABBV

📍 ABBV pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodBDVSFABBV
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, BDVSF + ABBV cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
BDVSF pays
ABBV pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

BDVSF
Annual income on $10K today (after 15% tax)
$319.62/yr
After 10yr DRIP, annual income (after tax)
$25,906.10/yr
ABBV
Annual income on $10K today (after 15% tax)
$265.10/yr
After 10yr DRIP, annual income (after tax)
$21,866.87/yr
At 15% tax rate, BDVSF beats the other by $4,039.23/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of BDVSF + ABBV for your $10,000?

BDVSF: 50%ABBV: 50%
100% ABBV50/50100% BDVSF
Portfolio after 10yr
$102.6K
Annual income
$28,101.74/yr
Blended yield
27.39%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on ABBV right now

BDVSF
No analyst data
Altman Z
3.8
Piotroski
6/9
ABBV
Analyst Ratings
27
Buy
12
Hold
1
Sell
Consensus: Buy
Price Target
$256.15
+20.1% upside vs current
Range: $223.00 — $299.00
Altman Z
2.0
Piotroski
8/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

BDVSF buys
0
ABBV buys
0
No recent congressional trades found for BDVSF or ABBV in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricBDVSFABBV
Forward yield3.76%3.12%
Annual dividend / share$0.49$6.65
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR36.7%40.6%
Portfolio after 10y$100.4K$104.7K
Annual income after 10y$30,477.76$25,725.73
Total dividends collected$72.4K$63.0K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: BDVSF vs ABBV ($10,000, DRIP)

YearBDVSF PortfolioBDVSF Income/yrABBV PortfolioABBV Income/yrGap
1← crossover$11,214$514.02$11,559$438.51$345.00ABBV
2$12,735$736.43$13,494$640.86$759.00ABBV
3$14,695$1,068.48$15,951$945.97$1.3KABBV
4$17,299$1,575.14$19,152$1,413.89$1.9KABBV
5$20,879$2,368.91$23,443$2,146.38$2.6KABBV
6$25,993$3,652.73$29,391$3,321.96$3.4KABBV
7$33,623$5,809.69$37,948$5,265.87$4.3KABBV
8$45,577$9,600.78$50,795$8,596.74$5.2KABBV
9$65,394$16,626.68$71,034$14,549.41$5.6KABBV
10$100,449$30,477.76$104,715$25,725.73$4.3KABBV

BDVSF vs ABBV: Complete Analysis 2026

BDVSFStock

The Bidvest Group Limited, an investment holding company, engages in services, trading, and distribution businesses in South Africa and internationally. The company operates through nine segments: Bidvest Automotive, Bidvest Commercial Products, Bidvest Financial Services, Bidvest Freight, Bidvest Branded Products, Bidvest Services South Africa, Bidvest Services International, Bidvest Properties, and Bidvest Corporate and Investments. It offers online motor retailing and develops systems. The company also manufactures and trades bathroom and plumbing products; distributes electrical cable and allied products; and offers motor vehicle accessories, as well as camping and outdoor equipment. In addition, it provides fleet management, foreign exchange services, insurance products, and other financial services; operates and supports terminals; provides international clearing, freight forwarding, integrated logistics, supply chain, and marine services; facilitates storage, handling, and movement of cargo via ocean freight, air freight, road, and rail. Further, the company supplies stationery, paper or printer cartridges, and packaging and data services; offers consumer-facing trading and distribution businesses offering luggage and travel accessories representing local and global brands; manufacture, market, and distribution of healthcare products to both the private and public market sectors. Additionally, it provides security, laundry, landscaping, food, travel, cargo and aviation, office water and coffee vending services to corporate and small to medium business clients; hygiene, cleaning, and facilities management services; owns, manages, and develops properties; and provides professional property services and consulting on all property-related matters; and provides treasury, secretarial, corporate finance, and governance services. The Bidvest Group Limited was founded in 1988 and is headquartered in Johannesburg, South Africa.

Full BDVSF Calculator →

ABBVHealthcare

AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheumatoid arthritis in adult patients; IMBRUVICA to treat adult patients with chronic lymphocytic leukemia (CLL), small lymphocytic lymphoma (SLL), and VENCLEXTA, a BCL-2 inhibitor used to treat adults with CLL or SLL; and MAVYRET to treat patients with chronic HCV genotype 1-6 infection. It also provides CREON, a pancreatic enzyme therapy for exocrine pancreatic insufficiency; Synthroid used in the treatment of hypothyroidism; Linzess/Constella to treat irritable bowel syndrome with constipation and chronic idiopathic constipation; Lupron for the palliative treatment of advanced prostate cancer, endometriosis and central precocious puberty, and patients with anemia caused by uterine fibroids; and Botox therapeutic. In addition, the company offers ORILISSA, a nonpeptide small molecule gonadotropin-releasing hormone antagonist for women with moderate to severe endometriosis pain; Duopa and Duodopa, a levodopa-carbidopa intestinal gel to treat Parkinson's disease; Lumigan/Ganfort, a bimatoprost ophthalmic solution for the reduction of elevated intraocular pressure (IOP) in patients with open angle glaucoma (OAG) or ocular hypertension; Ubrelvy to treat migraine with or without aura in adults; Alphagan/ Combigan, an alpha-adrenergic receptor agonist for the reduction of IOP in patients with OAG; and Restasis, a calcineurin inhibitor immunosuppressant to increase tear production, as well as other eye care products. AbbVie Inc. has a research collaboration with Dragonfly Therapeutics, Inc. The company was incorporated in 2012 and is headquartered in North Chicago, Illinois.

Full ABBV Calculator →
📬

Get this BDVSF vs ABBV comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

BDVSF vs SCHDBDVSF vs JEPIBDVSF vs OBDVSF vs KOBDVSF vs MAINBDVSF vs JNJBDVSF vs MRKBDVSF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.